🙌 Celebrating Women in Science & Medicine! On #InternationalWomensDay, we honor the incredible contributions of women in #NeuroOncology, research, and healthcare. EANO is proud to support and empower women in the field — today and every day! 💜 #IWD2024 #WomenInScience #btsm

This study explores the impact of the OLIG2 inhibitor CT-179 in suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma. Now available open access in nature! 🔗Learn more: nature.com/articles/s4146… #EANOessentials #NeuroOncology #Medulloblastoma #OpenAccess #btsm

🧠 A recent publication in nature Scientific Reports covers an effective MRI perfusion threshold-based workflow to triage additional 18F-FET PET in posttreatment high-grade glioma.🔓🔗Read more: nature.com/articles/s4159… #EANOessentials #NeuroOncology #Glioma #BrainTumors #PET

#Cancer research needs #neuroscience and neuroscientists. Sharing some thoughts on #CancerNeuroscience, together with Frank Winkler. nature.com/articles/s4159…

🧠New in Nature Medicine (#OpenAccess): This study explores the impact of neoadjuvant triplet immune checkpoint blockade in newly diagnosed #glioblastoma.🔗Full article: nature.com/articles/s4159… #EANOessentials #NeuroOncology #Glioma #Immunotherapy

🧬This research examines the single-cell atlas of endothelial & mural cells across primary & metastatic brain tumors. Published in Immunity. 🔗cell.com/immunity/fullt… #Glioma #NeuroOncology #EANOessentials #BrainMetastasis #TumorMicroenvironment

🧠 A new article on the characteristics, outcomes, and prognostic factors of young patients with WHO grade 3 oligodendrogliomas (IDH-mutant and 1p/19q codeleted) can be found in Cancer.📰 Full article: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… #EANOessentials #NeuroOncology #Oligodendroglioma

This research examines the single-cell and spatial genomic landscape of non-small cell lung cancer (#NSCLC) brain metastases. 🔗 Read the full article in Nature Medicine 👉 rdcu.be/eh8y7 #EANOessentials #NeuroOncology #BrainMetastases #btsm

Early-career researchers, this one’s for you! 🚀 The #EANO Youngster Award recognizes promising young professionals in #NeuroOncology. Apply today and showcase your work at #EANO2025! eano.eu/eano2025/ #btsm

🧠Recently published in Neuro-Oncology: Multimodal glioma immunotherapy combining TLR9-targeted STAT3 antisense oligodeoxynucleotides with PD1 immune checkpoint blockade. Full article 👉doi.org/10.1093/neuonc… #EANOessentails #NeuroOncology #immunotherapy #glioma

The article “Functional connectivity between #tumor region and resting-state networks as imaging #biomarker for overall survival in recurrent #gliomas diagnosed by O-(2-[18F]fluoroethyl)-L-tyrosine PET” is now out! Read the article or #LaySummary here: academic.oup.com/noa/article/7/…

Interested in telomere maintenance? 📢 Open PhD position in experimental oncology! Please RT and distribute. jobs-uk-koeln.onlyfy.jobs/job/sypg9i9nub…

🧠 An article discussing the molecular interactions between metastases and immune cells within the leptomeninges is now available in @nature.com. 🔗 nature.com/articles/s4158… #EANOessentials #glioblastoma #NeuroOncology #leptomeningeal #metastases

💪 Neuro-Oncology Pediatrics – the new #OpenAccess journal by EANO & SNO for #pediatric & AYA #NeuroOncology. 📝 Now open for submissions! 🔗 academic.oup.com/neuro-onc-peds Editor-in-Chief: Sabine Mueller Executive Editors: Marta A. Roldán (EANO), Pratiti “Mimi” Bandopadhayay (SNO)

Live from #ASCO25 in Chicago: presentation of latest results on HER3-DXd efficacy and safety in patients with leptomeningeal metastatic disease of solid tumors - with simultaneous publication in Nature Medicine. Learn more: doi.org/10.1038/s41591… #NeuroOncology

📢 We are discontinuing our presence on X. To foster an inclusive, respectful, and scientific community, join us on @Bluesky. Stay also connected with #EANO on: 🔹 LinkedIn 🔹 Facebook 🔹 Instagram 🔹 YouTube #NeuroOncology

Online Now: A unified pan-cancer proteome atlas dlvr.it/TLPtvc

🚨 One week left! Submit your Late Breaking Abstract for #EANO2025 by June 25, 23:59 CEST! Share your latest high-impact data in neuro-oncology 🧠✨ Submit here 👉eano.eu/eano2025/abstr… #NeuroOncology

Don’t miss the next YO4YO Virtual Session with Ranjit Bindra,MD/PhD & Emre Kocakavuk, MD, PhD 📌 How to move from bedside to bench to biotech 📅 8 July 2025 🕒 15:00–16:00 CEST 🔗 ow.ly/eF7I50Wi97y

There's still time to register and join us tomorrow (7/9) for the #ASNR and #ASFNR webinar. Join us at 1:00 pm ET (note the different time) for Seeing The Invisible: PET/MRI Advancements in Brain Tumor Evaluation (Presented by ASNR and ASFNR). Register: ow.ly/kWgK50WgMyI